Wilmer Cutler Pickering Hale and Dorr advised Apellis Pharmaceuticals on the deal.Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Beam Therapeutics Inc. (Nasdaq: BEAM), announced that they had…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
